Literature DB >> 13211824

The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients.

A J JOHNSON, P R GOGER, W S TILLETT.   

Abstract

Entities:  

Keywords:  NUCLEASES; PANCREAS

Mesh：

Substances：

Year:  1954        PMID： 13211824      PMCID： PMC1072599          DOI： 10.1172/JCI103048

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  27 in total

1.  Studies on desoxyribonuclease in systemic lupus erythematosus; non-participation of serum desoxyribonuclease in the L.E. phenomenon.

Authors:  N B KURNICK; S PARISER; L I SCHWARTZ; S L LEE; W IRVINE
Journal:  J Clin Invest       Date:  1952-12       Impact factor: 14.808

2.  Presence of desoxyribonuclease activity in human serum.

Authors:  F WROBLEWSKI; O BODANSKY
Journal:  Proc Soc Exp Biol Med       Date:  1950-06

3.  Deoxyribonuclease in the treatment of purulent bronchitis.

Authors:  P C ELMES; J C WHITE
Journal:  Thorax       Date:  1953-12       Impact factor: 9.139

4.  The viscosimetric determination of desoxyribonuclease inhibition.

Authors:  H H HENSTELL; R I FREEDMAN
Journal:  Cancer Res       Date:  1952-05       Impact factor: 12.701

5.  The use of streptokinase-streptodornase in the treatment of chronic empyema; with an interpretive discussion of enzymatic actions in the field of intrathoracic diseases.

Authors:  W S TILLETT; S SHERRY; C T READ
Journal:  J Thorac Surg       Date:  1951-04

6.  A simple office procedure for demonstrating lupus erythematosus cells in peripheral blood.

Authors:  H B MATHIS
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

7.  Technic for demonstrating L. E. (lupus erythematosus) cells in blood.

Authors:  T B MAGATH; V WINKLE
Journal:  Am J Clin Pathol       Date:  1952-06       Impact factor: 2.493

8.  Anti (streptococcal) desoxyribonuclease. Occurrence in the sera of patients treated with streptococcal concentrates containing streptodornase.

Authors:  G N HAZLEHURST
Journal:  J Immunol       Date:  1950-07       Impact factor: 5.422

9.  Crystalline desoxyribonuclease; digestion of thymus nucleic acid; the kinetics of the reaction.

Authors:  M KUNITZ
Journal:  J Gen Physiol       Date:  1950-03       Impact factor: 4.086
View more
  9 in total

1.  CHANGES IN SERUM AND URINARY URIC ACID WITH THE DEVELOPMENT OF SYMPTOMATIC GOUT.

Authors:  J H AYVAZIAN; I F AYVAZIAN
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

2.  [Parentreal use of enzymes in medicine].

Authors:  G J MARTIN; J M BEILER
Journal:  Klin Wochenschr       Date:  1958-06-15

3.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

4.  Using Pulmozyme DNase treatment in lentiviral vector production.

Authors:  Aaron Shaw; Daniela Bischof; Aparna Jasti; Aaron Ernstberger; Troy Hawkins; Kenneth Cornetta
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

5.  The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.

Authors:  P G Frost; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

6.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis.

Authors:  Svetlana N Zykova; Anders A Tveita; Ole Petter Rekvig
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 8.  Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases.

Authors:  Bhargavi Duvvuri; Christian Lood
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

9.  Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model.

Authors:  Catalina Trejo-Becerril; Enrique Pérez-Cardenas; Blanca Gutiérrez-Díaz; Desiree De La Cruz-Sigüenza; Lucía Taja-Chayeb; Mauricio González-Ballesteros; Patricia García-López; José Chanona; Alfonso Dueñas-González
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.